Jeffrey M. Conroy

6.1k total citations · 2 hit papers
133 papers, 3.7k citations indexed

About

Jeffrey M. Conroy is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jeffrey M. Conroy has authored 133 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Oncology, 43 papers in Molecular Biology and 43 papers in Cancer Research. Recurrent topics in Jeffrey M. Conroy's work include Cancer Immunotherapy and Biomarkers (44 papers), Cancer Genomics and Diagnostics (34 papers) and Genomic variations and chromosomal abnormalities (32 papers). Jeffrey M. Conroy is often cited by papers focused on Cancer Immunotherapy and Biomarkers (44 papers), Cancer Genomics and Diagnostics (34 papers) and Genomic variations and chromosomal abnormalities (32 papers). Jeffrey M. Conroy collaborates with scholars based in United States, Japan and Netherlands. Jeffrey M. Conroy's co-authors include Norma J. Nowak, Sarabjot Pabla, Devin McQuaid, Mary Nesline, Antoine M. Snijders, Paul DePietro, Bing Huey, Daniel Pinkel, Ajay N. Jain and Shumei Kato and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Jeffrey M. Conroy

121 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assembly of microarrays for genome-wide measurement of DNA copy number

2001 712 citations Antoine M. Snijders, Norma J. Nowak et al. profile →
Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy

2022 195 citations Shumei Kato, Mary Nesline et al. profile →

Peers

Jeffrey M. Conroy

GENET

ONCOL

PRM

Lidia Larizza Italy

John R.W. Yates United Kingdom

Arthur R. Brothman United States

Erik A. Sistermans Netherlands

Rong Mao United States

Philippe Jonveaux France

J.-M. Lalouel United States

Kenjiro Kosaki Japan

Célia Bádenas Spain

Joep de Ligt Netherlands

Lidia Larizza Italy

Jeffrey M. Conroy

3.7k ×2.1

2.3k ×1.5

GENET

530 ×0.6

ONCOL

573 ×0.7

496 ×1.0

PRM

Citations per year, relative to Jeffrey M. Conroy Jeffrey M. Conroy (= 1×) peers Lidia Larizza

Countries citing papers authored by Jeffrey M. Conroy

Since Specialization

Citations

This map shows the geographic impact of Jeffrey M. Conroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey M. Conroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey M. Conroy more than expected).

Fields of papers citing papers by Jeffrey M. Conroy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey M. Conroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey M. Conroy. The network helps show where Jeffrey M. Conroy may publish in the future.

Co-authorship network of co-authors of Jeffrey M. Conroy

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey M. Conroy. A scholar is included among the top collaborators of Jeffrey M. Conroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey M. Conroy. Jeffrey M. Conroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nishizaki, Daisuke, Razelle Kurzrock, Hirotaka Miyashita, et al.. (2024). Viewing the immune checkpoint VISTA: landscape and outcomes across cancers. ESMO Open. 9(4). 102942–102942. 18 indexed citations

Seager, R. J., et al.. (2024). Immune checkpoint expression and co-expression landscape in gastroesophageal adenocarcinoma. SHILAP Revista de lepidopterología. 3. 100045–100045.

Nesline, Mary, Vivek Subbiah, Rebecca A. Previs, et al.. (2024). The Impact of Prior Single-Gene Testing on Comprehensive Genomic Profiling Results for Patients with Non-Small Cell Lung Cancer. Oncology and Therapy. 12(2). 329–343. 3 indexed citations

Nesline, Mary, Rebecca A. Previs, Grace K. Dy, et al.. (2023). PD-L1 Expression by RNA-Sequencing in Non-Small Cell Lung Cancer: Concordance with Immunohistochemistry and Associations with Pembrolizumab Treatment Outcomes. Cancers. 15(19). 4789–4789. 4 indexed citations

Seager, R. J., Shuang Gao, Mary Nesline, et al.. (2023). Sex-Specific Effects of Body Composition on Tumor Microenvironment in Non–Small Cell Lung Cancer. Annals of Thoracic Surgery Short Reports. 1(3). 465–468.

Kurzrock, Razelle, Daisuke Nishizaki, Hirotaka Miyashita, et al.. (2023). Pan‐cancer analysis of TIM‐3 transcriptomic expression reveals high levels in pancreatic cancer and interpatient heterogeneity. Cancer Medicine. 13(1). e6844–e6844. 9 indexed citations

Eisner, Joel R., Gregory M. Mayhew, James M. Davison, et al.. (2023). Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non–Small Cell Lung Cancer: The Piedmont Study. Clinical Cancer Research. 29(16). 3203–3213.

Adashek, Jacob J., Shumei Kato, Daisuke Nishizaki, et al.. (2023). LAG‐3 transcriptomic expression patterns across malignancies: Implications for precision immunotherapeutics. Cancer Medicine. 12(12). 13155–13166. 24 indexed citations

Stephen, Bettzy, Joud Hajjar, Shrutii Sarda, et al.. (2023). T-cell receptor beta variable gene polymorphism predicts immune-related adverse events during checkpoint blockade immunotherapy. Journal for ImmunoTherapy of Cancer. 11(8). e007236–e007236. 9 indexed citations

10.

Zhu, Qianqian, Qiang Hu, Lori Shepherd, et al.. (2015). The Impact of DNA Input Amount and DNA Source on the Performance of Whole-Exome Sequencing in Cancer Epidemiology. Cancer Epidemiology Biomarkers & Prevention. 24(8). 1207–1213. 20 indexed citations

11.

Golubovskaya, Vita, et al.. (2015). Down-regulation of ALDH1A3, CD44 or MDR1 sensitizes resistant cancer cells to FAK autophosphorylation inhibitor Y15. Journal of Cancer Research and Clinical Oncology. 141(9). 1613–1631. 22 indexed citations

12.

Golubovskaya, Vita, et al.. (2014). Gene Expression Profiling Identifies Important Genes Affected by R2 Compound Disrupting FAK and P53 Complex. Cancers. 6(1). 166–178. 3 indexed citations

13.

Bartos, Jeremy D., Daniel P. Gaile, Jeffrey M. Conroy, et al.. (2007). aCGH local copy number aberrations associated with overall copy number genomic instability in colorectal cancer: Coordinate involvement of the regions including BCR and ABL. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 615(1-2). 1–11. 14 indexed citations

14.

Sait, Sheila N.J., et al.. (2007). Translocation (4;11)(p12;q23) with rearrangement of FRYL and MLL in therapy-related acute myeloid leukemia. Cancer Genetics and Cytogenetics. 177(2). 143–146. 4 indexed citations

15.

Nadiminty, Nagalakshmi, Wei Lou, Soo Ok Lee, et al.. (2006). Prostate-Specific Antigen Modulates Genes Involved in Bone Remodeling and Induces Osteoblast Differentiation of Human Osteosarcoma Cell Line SaOS-2. Clinical Cancer Research. 12(5). 1420–1430. 45 indexed citations

16.

Snijders, Antoine M., Norma J. Nowak, Bing Huey, et al.. (2005). Mapping segmental and sequence variations among laboratory mice using BAC array CGH. Genome Research. 15(2). 302–311. 65 indexed citations

17.

Varma, Rajesh, Huayi Huang, Norma J. Nowak, et al.. (2005). Array comparative genomic hybridisation (aCGH) analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from Western New York. British Journal of Cancer. 93(6). 699–708. 23 indexed citations

18.

Rossi, Michael R., Jeffrey M. Conroy, Devin McQuaid, et al.. (2005). Array CGH analysis of pediatric medulloblastomas. Genes Chromosomes and Cancer. 45(3). 290–303. 46 indexed citations

19.

Christ, Laurie A., Carol A. Crowe, Mark A. Micale, Jeffrey M. Conroy, & Stuart Schwartz. (1999). Chromosome Breakage Hotspots and Delineation of the Critical Region for the 9p-Deletion Syndrome. The American Journal of Human Genetics. 65(5). 1387–1395. 74 indexed citations

20.

Conroy, Jeffrey M., Theresa A. Grebe, Karen D. Tsuchiya, et al.. (1997). Balanced Translocation 46, XY, t(2;15)(q37.2;q11.2) Associated with Atypical Prader-Willi Syndrome. The American Journal of Human Genetics. 61(2). 388–394. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact